Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.

Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...

Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...

Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...

Congress removed from a list of programmes from which the Trump administration wants to cut funds, doesn’t cancel the cuts to ...

President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...

This month, the White House released a statement that confirmed Trump “underwent a comprehensive examination” that revealed he had chronic venous insufficiency. Here's what that means, according to ...

Medicaid and ACA, the homeless crisis, children's health, 'black box' drug warnings, nutrition and SNAP, maternity care, and more.

The Bill and Melinda Gates Foundation and the Wellcome Trust have pledged R100,000,000.00 each. They put a condition – that each R100 million they contribute be matched by R200 million from our own ...